Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

75.29
+0.65000.87%
Post-market: 75.290.00000.00%18:20 EDT
Volume:4.18M
Turnover:313.60M
Market Cap:44.20B
PE:10.73
High:75.57
Open:74.69
Low:74.43
Close:74.64
52wk High:83.00
52wk Low:64.89
Shares:587.10M
Float Shares:581.10M
Volume Ratio:1.08
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.02
EPS(LYR):6.98
ROE:15.53%
ROA:8.42%
PB:4.19
PE(LYR):10.78

Loading ...

Edwards Lifesciences raises annual sales forecast on strong demand for heart devices

Reuters
·
Jul 25

Stock Track | Edwards Lifesciences Soars 7.54% After-Hours on Strong Q2 Earnings, Raised Guidance

Stock Track
·
Jul 25

Stock Track | Edwards Lifesciences Soars 7.54% After-Hours on Strong Q2 Results and Raised Guidance

Stock Track
·
Jul 25

Edwards Lifesciences Reports 11.9% Q2 Sales Growth to $1.53 Billion, Adjusted EPS at $0.67

Reuters
·
Jul 25

Edwards Lifesciences Q2 Adj. EPS $0.67 Beats $0.62 Estimate, Sales $1.532B Beat $1.488B Estimate

Benzinga
·
Jul 25

Edwards Lifesciences Outlook Q3 Adj EPS $0.54 - $0.60 VS Ibes Estimate $0.60

THOMSON REUTERS
·
Jul 25

Edwards Lifesciences Outlook FY REV $5.9 Bln - $6.1 Bln VS Ibes Estimate $5.91 Bln

THOMSON REUTERS
·
Jul 25

Edwards Lifesciences Outlook FY Adj EPS High End of $2.40 to $2.50 Range VS Ibes Estimate $2.48

THOMSON REUTERS
·
Jul 25

Edwards Lifesciences Q2 Adjusted EPS USD 0.67 VS. Ibes Estimate USD 0.62

THOMSON REUTERS
·
Jul 25

Edwards Lifesciences Q2 Gross Profit USD 1,187.8 Million

THOMSON REUTERS
·
Jul 25

Edwards Lifesciences Outlook Q3 Adjusted EPS USD 0.54-0.6

THOMSON REUTERS
·
Jul 25

BRIEF-FDA Says Edwards Lifesciences Is Recalling Arterial Cannula

Reuters
·
Jul 25

FDA: Edwards Lifesciences Is Recalling Arterial Cannula Due to Risk of Wire Exposure

THOMSON REUTERS
·
Jul 25

FDA: Identified Arterial Cannula Recall as the Most Serious Type

THOMSON REUTERS
·
Jul 25

Edwards Lifesciences Corp expected to post earnings of 62 cents a share - Earnings Preview

Reuters
·
Jul 23

Truist Securities Adjusts Edwards Lifesciences Price Target to $81 From $75

MT Newswires Live
·
Jul 21

Edwards Lifesciences Corporation to Announce Operating Results for the Quarter Ended June 30, 2025

Reuters
·
Jul 18

Edwards Lifesciences Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Jul 15

Argus Initiates Edwards Lifesciences at Buy, $90 Price Target

MT Newswires Live
·
Jul 11

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jul 10